The sales are small relative to market cap and all under 10b5-1 plans, so no bearish signal. Monitor the next 10-Q for any change in insider selling patterns or plan modifications.
Price Chart
How similar events traded
Executive Summary
Four Progyny insiders, including the CEO, Executive Chairman, and CFO, sold shares in open-market transactions totaling approximately $2.0M over the past week. All sales were under 10b5-1 plans and follow the company's Q3 earnings beat and raised guidance reported on November 4. The total value represents about 0.07% of market cap, well below the 0.1% materiality threshold, making this a routine cluster of planned sales.
Key Financial Metrics
Key Facts
- Four insiders sold shares: Executive Chairman David Schlanger ($1.25M), CEO Peter Anevski ($655K), CFO Mark Livingston ($64K), and Chief Product Officer Geoffrey Clapp ($28K)
- Total open-market sales of approximately $2.0M represent ~0.07% of PGNY's $2.7B market cap
- All sales were executed under 10b5-1 trading plans, indicating pre-planned transactions
- The cluster follows Q3 2026 earnings (Nov 4) where revenue grew 8.9% YoY to $341.3M and full-year guidance was raised
- CEO Anevski also exercised derivative securities (non-cash) on Nov 9-10, converting options into shares before selling
Financial Impact
Total insider sales of ~$2.0M, or 0.07% of market cap, which is below the 0.1% materiality threshold
Risk Factors
- Insider sales under 10b5-1 plans are pre-scheduled and not reactive to current events, but large future plan sales could add selling pressure
- CEO and Chairman exercised and sold a significant number of shares (combined ~$14M in total sales across all trades in the window), which could indicate portfolio diversification rather than bearish conviction
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PGNY-1794605069094 |
Track record
26 reports on PGNY
3 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +6.43% at T+5 after the Nov 4, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Viewing Entry $36.75 Now $37.15 +1.09% settles Nov 23
- Nov 12, 20264d ago Insider Cluster Bearish 4/10 Entry $36.18 Now $37.15 −2.68% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $36.58 Now $37.15 +1.56% settles Nov 19
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $36.50 Now $37.15 +1.78% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $36.43 Now $37.15 +1.98% settles Nov 17
- Nov 5, 202611d ago 144 Neutral 3/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 3/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
- Nov 4, 202612d ago 8-K Bullish 6/10 No price data
- Nov 4, 202612d ago Press Release Bullish 6/10 Entry $34.37 to $36.58 Now $37.15 +8.09% ▲ +6.43% +3.14% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers